We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+9.88%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.45B
AUM Growth
+$379M
Cap. Flow
+$62.7M
Cap. Flow %
1.15%
Top 10 Hldgs %
26.99%
Holding
161
New
18
Increased
65
Reduced
42
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 43.08%
2 Technology 23.47%
3 Industrials 13.06%
4 Consumer Discretionary 7.01%
5 Utilities 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICPT
126
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$6.73M 0.12%
501,033
-298,967
-37% -$5.17M
EGP icon
127
EastGroup Properties
EGP
$11.2B
$5.5M 0.1%
33,255
-17,553
-35% -$2.86M
RCUS icon
128
Arcus Biosciences
RCUS
$3.55B
$4.38M 0.08%
240,000
IONS icon
129
Ionis Pharmaceuticals
IONS
$8.6B
$3.93M 0.07%
110,000
NEE.PRR
130
DELISTED
NextEra Energy, Inc. 6.926% Corporate Units
NEE.PRR
-75,000
Closed -$3.58M
ADCT icon
131
ADC Therapeutics
ADCT
$134M
$3.27M 0.06%
1,675,959
-204,000
-11% -$753K
ALXO icon
132
ALX Oncology
ALXO
$261M
$3.01M 0.06%
664,829
-237,171
-26% -$1.8M
TRML
133
DELISTED
Tourmaline Bio
TRML
$2.93M 0.05%
156,109
RXO icon
134
RXO
RXO
$3.34B
$2.26M 0.04%
115,000
AIP icon
135
Arteris
AIP
$1.38B
$2.21M 0.04%
522,805
-91,368
-15% -$478K
FRLN
136
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$2.16M 0.04%
313,509
-81,209
-21% -$630K
PTCT icon
137
PTC Therapeutics
PTCT
$5.68B
$1.65M 0.03%
+34,047
New +$1.56M
WDAY icon
138
Workday
WDAY
$39.6B
$449K 0.01%
2,176
+329
+18% +$59.9K
ZTS icon
139
Zoetis
ZTS
$32.4B
$335K 0.01%
2,015
-11,549
-85% -$1.89M
NOW icon
140
ServiceNow
NOW
$115B
$334K 0.01%
3,590
+1,210
+51% +$105K
EW icon
141
Edwards Lifesciences
EW
$49.6B
$333K 0.01%
4,030
+1,423
+55% +$112K
NEE icon
142
NextEra Energy
NEE
$181B
$277K 0.01%
3,594
+1,387
+63% +$107K
TSM icon
143
TSMC
TSM
$2.1T
$189K ﹤0.01%
2,027
+483
+31% +$43.4K
NVDA icon
144
NVIDIA
NVDA
$4.86T
$101K ﹤0.01%
3,630
-1,990
-35% -$43.1K
GTM
145
ZoomInfo Technologies
GTM
$973M
$26.4K ﹤0.01%
1,067
-3,206,091
-100% -$82.3M
MDB icon
146
MongoDB
MDB
$27.1B
$18.9K ﹤0.01%
+81
New +$17K
GNRC icon
147
Generac Holdings
GNRC
$11.6B
$11.1K ﹤0.01%
+103
New +$11.9K
XPO icon
148
XPO
XPO
$23.5B
$6.63K ﹤0.01%
208
-114,792
-100% -$4.13M
DLO icon
149
CALL
dLocal
DLO
$4.44B
$70 ﹤0.01%
+3,900
New +$61.4K
ARE icon
150
Alexandria Real Estate Equities
ARE
$8.97B
-32,335
Closed -$4.71M

Similar funds

Eventide Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Eventide Asset Management held 161 positions worth $5.45B, up 7.5% from $5.07B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Eventide Asset Management's Q1 2023 filing shows 18 new, 65 increased, 42 reduced and 14 closed positions. Its largest new stake was Lithia Motors: 125,499 shares worth $28.7M. The largest sale was ZoomInfo Technologies, an estimated $82.3M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 43% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q1 2023 buy was Lithia Motors: 125,499 shares worth $28.7M.
  • Eventide Asset Management added most to Doximity in Q1 2023, an estimated $43.7M increase.
  • Eventide Asset Management's biggest Q1 2023 reduction was ZoomInfo Technologies, cutting an estimated $82.3M.
  • Eventide Asset Management fully exited Bicycle Therapeutics in Q1 2023, selling an estimated $25.3M.
  • Eventide Asset Management's ten largest holdings make up 27% of its $5.45B portfolio in Q1 2023.
  • Eventide Asset Management opened 18 new positions and closed 14 in Q1 2023.
  • Eventide Asset Management's portfolio value rose 7.5% quarter-over-quarter to $5.45B.

Based on Eventide Asset Management's 13F filing for Q1 2023, filed 15 May 2023.